HK1034969A1 - Dihydroxyhexanoic acid derivatives. - Google Patents

Dihydroxyhexanoic acid derivatives.

Info

Publication number
HK1034969A1
HK1034969A1 HK01105717A HK01105717A HK1034969A1 HK 1034969 A1 HK1034969 A1 HK 1034969A1 HK 01105717 A HK01105717 A HK 01105717A HK 01105717 A HK01105717 A HK 01105717A HK 1034969 A1 HK1034969 A1 HK 1034969A1
Authority
HK
Hong Kong
Prior art keywords
acid derivatives
dihydroxyhexanoic acid
dihydroxyhexanoic
derivatives
acid
Prior art date
Application number
HK01105717A
Other languages
English (en)
Inventor
John Charles Kath
Matthew Frank Brown
Christopher Stanley Poss
Original Assignee
Pfizer Product Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Product Inc filed Critical Pfizer Product Inc
Publication of HK1034969A1 publication Critical patent/HK1034969A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
HK01105717A 1998-02-05 2001-08-15 Dihydroxyhexanoic acid derivatives. HK1034969A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05
PCT/IB1999/000067 WO1999040061A2 (en) 1998-02-05 1999-01-18 Novel dihydroxyhexanoic acid derivatives

Publications (1)

Publication Number Publication Date
HK1034969A1 true HK1034969A1 (en) 2001-11-09

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01105717A HK1034969A1 (en) 1998-02-05 2001-08-15 Dihydroxyhexanoic acid derivatives.

Country Status (37)

Country Link
EP (1) EP1051405B1 (bg)
JP (1) JP3693916B2 (bg)
KR (1) KR100385529B1 (bg)
CN (1) CN1177834C (bg)
AP (1) AP992A (bg)
AR (1) AR016175A1 (bg)
AT (1) ATE337307T1 (bg)
AU (1) AU752407B2 (bg)
BG (1) BG104726A (bg)
BR (1) BR9907655A (bg)
CA (1) CA2320388C (bg)
DE (1) DE69932920T2 (bg)
DZ (1) DZ2717A1 (bg)
EA (1) EA003137B1 (bg)
ES (1) ES2268847T3 (bg)
GT (1) GT199900011A (bg)
HK (1) HK1034969A1 (bg)
HR (1) HRP20000529B1 (bg)
HU (1) HUP0100832A3 (bg)
IL (1) IL137330A0 (bg)
IS (1) IS5562A (bg)
MA (1) MA26603A1 (bg)
MY (1) MY133125A (bg)
NO (1) NO20003965D0 (bg)
NZ (1) NZ505724A (bg)
OA (1) OA11448A (bg)
PA (1) PA8467301A1 (bg)
PE (1) PE20000243A1 (bg)
PL (1) PL342817A1 (bg)
SK (1) SK11262000A3 (bg)
TN (1) TNSN99013A1 (bg)
TR (1) TR200002248T2 (bg)
TW (1) TW470744B (bg)
UA (1) UA57824C2 (bg)
WO (1) WO1999040061A2 (bg)
YU (1) YU47100A (bg)
ZA (1) ZA99873B (bg)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1152752A1 (en) * 1999-01-29 2001-11-14 Millennium Pharmaceuticals, Inc. Methods for preventing graft rejection and ischemia-reperfusion injury
EP1204643B1 (en) * 1999-08-20 2008-06-04 Dow AgroSciences LLC Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
NZ520075A (en) * 2000-02-04 2004-02-27 Pfizer Prod Inc Heterocyclic amide derivatives
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
DE60233874D1 (de) * 2001-06-22 2009-11-12 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
OA12625A (en) 2001-06-22 2006-06-12 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug.
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
AU2003223050A1 (en) * 2002-05-14 2003-11-11 Pfizer Products Inc. Methods for manufacture of dihydro-furan-2-one derivatives
KR20050006256A (ko) * 2002-05-14 2005-01-15 화이자 프로덕츠 인크. 디히드록시헥산산 유도체, 이들의 중간체, 및 제조 방법
BR0313428A (pt) 2002-08-12 2005-06-28 Pfizer Prod Inc Composições farmacêuticas de drogas semi-ordenados e polìmeros
BR0313378A (pt) * 2002-08-12 2005-07-12 Pfizer Producs Inc Formas cristalinas da [4carbamoil-1-(3-fluorobenzil)-2,7-dihidróxi-7-metil-o ctil]-amida do ácido quinoxalina-2-carboxìlico
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
EP0708085B1 (en) * 1994-10-19 2002-07-17 Novartis AG Antiviral ethers of aspartate protease substrate isosteres
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
ATE337307T1 (de) 2006-09-15
CA2320388C (en) 2005-05-03
AU752407B2 (en) 2002-09-19
CN1177834C (zh) 2004-12-01
AU1778999A (en) 1999-08-23
JP2002502839A (ja) 2002-01-29
MA26603A1 (fr) 2004-12-20
EA200000741A1 (ru) 2001-02-26
NO20003965L (bg) 2000-10-03
HUP0100832A3 (en) 2002-03-28
ES2268847T3 (es) 2007-03-16
DZ2717A1 (fr) 2003-09-01
HUP0100832A2 (hu) 2002-02-28
EP1051405A2 (en) 2000-11-15
OA11448A (en) 2003-11-18
UA57824C2 (uk) 2003-07-15
CA2320388A1 (en) 1999-08-12
BR9907655A (pt) 2000-10-24
JP3693916B2 (ja) 2005-09-14
DE69932920T2 (de) 2007-02-08
KR100385529B1 (ko) 2003-05-27
HRP20000529B1 (en) 2004-12-31
NO20003965D0 (no) 2000-08-04
HRP20000529A2 (en) 2001-08-31
AP992A (en) 2001-08-06
AR016175A1 (es) 2001-06-20
IS5562A (is) 2000-07-14
YU47100A (sh) 2002-11-15
WO1999040061A2 (en) 1999-08-12
KR20010040684A (ko) 2001-05-15
MY133125A (en) 2007-10-31
ZA99873B (en) 2000-08-04
PL342817A1 (en) 2001-07-02
TNSN99013A1 (fr) 2005-11-10
DE69932920D1 (de) 2006-10-05
EA003137B1 (ru) 2003-02-27
IL137330A0 (en) 2001-07-24
TW470744B (en) 2002-01-01
BG104726A (bg) 2001-04-30
EP1051405B1 (en) 2006-08-23
CN1290255A (zh) 2001-04-04
WO1999040061A3 (en) 1999-10-21
PA8467301A1 (es) 2000-05-24
SK11262000A3 (sk) 2001-01-18
AP9901457A0 (en) 1999-03-31
GT199900011A (es) 2000-07-20
TR200002248T2 (tr) 2000-12-21
PE20000243A1 (es) 2000-04-07
NZ505724A (en) 2003-02-28

Similar Documents

Publication Publication Date Title
ZA992629B (en) (4-arylsulfonylamino)-tetrahydropyran-4-caboxylic acid hydroxamides.
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
ZA99254B (en) Benzosulfone derivatives.
EG24140A (en) New 3-aryl-2-hydroxypropionic acid derivative
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA992630B (en) Bicyclic hydroxamic acid derivatives.
IL140358A0 (en) Aminomethylarboxylic acid derivatives
HK1029575A1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives.
ZA200007593B (en) Quinoline Derivatives.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
ZA99567B (en) Aryl-acrylic acid esters.
ZA981602B (en) Novel hexanoic acid derivatives.
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en) Amidocarboxylic acid derivatives
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
ZA991272B (en) Novel thiobenzamides.
HK1034969A1 (en) Dihydroxyhexanoic acid derivatives.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA991550B (en) Cyclohexanediole derivatives.
AU1268400A (en) Isothiazolecarboxylic acid derivatives
ZA993123B (en) Trisresorcinyltriazines.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090118